SCHEMBL24569877

SCHEMBL24569877

CC(C)(C)OC(=O)N1C[C@@](O)(c2ccccc2)C[C@@H]1C(=O)Nc1cc(C(N)(CCC2CC2)c2ccncc2)ccc1F

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 19/20 0.54
▸ F10 P00742 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24012229 0.91 KLKB1 (0.64) KLKB1F10
SCHEMBL24011969 0.90 KLKB1 (0.64) KLKB1
SCHEMBL24570331 0.89 KLKB1 (0.64) KLKB1
SCHEMBL24012223 0.89 KLKB1 (0.56) KLKB1
SCHEMBL31456786 0.88 KLKB1 (0.46) KLKB1F10
SCHEMBL29638925 0.88 KLKB1 (0.51) KLKB1F10
SCHEMBL24569826 0.88 KLKB1 (0.57) KLKB1
SCHEMBL21700374 0.88 KLKB1 (0.50) KLKB1F10
SCHEMBL20584364 0.88 KLKB1 (0.46) KLKB1F10
SCHEMBL22683222 0.88 KLKB1 (0.50) KLKB1F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4019022-A1 HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2022-06-29 — — EP disclosed
Send feedback